Structural doubling time predicts overall survival in patients with medullary thyroid cancer in patients with rapidly progressive metastatic medullary thyroid cancer treated with molecular targeted therapies.
Yeh, Tiffany, Yeung, Michele, Sherman, Eric J, Tuttle, R Michael, Sabra, MonaJournal:
Thyroid
DOI:
10.1089/thy.2019.0579
Date:
March, 2020
File:
PDF, 457 KB
2020